Cargando…

Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis

Our aim was to compare the outcomes of Impella with extracorporeal life support (ECLS) in patients with post-cardiac arrest cardiogenic shock (CS) complicating acute myocardial infarction (AMI). This was a retrospective study of patients resuscitated from out of hospital cardiac arrest (OHCA) with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syntila, Styliani, Chatzis, Georgios, Markus, Birgit, Ahrens, Holger, Waechter, Christian, Luesebrink, Ulrich, Divchev, Dimitar, Schuett, Harald, Tsalouchidou, Panagiota-Eleni, Jerrentrup, Andreas, Parahuleva, Mariana, Schieffer, Bernhard, Karatolios, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396971/ https://www.ncbi.nlm.nih.gov/pubmed/34441879 http://dx.doi.org/10.3390/jcm10163583

Ejemplares similares

Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis
por: Karatolios, Konstantinos, et al.
Publicado: (2020)

Biventricular Unloading with Impella and Venoarterial Extracorporeal Membrane Oxygenation in Severe Refractory Cardiogenic Shock: Implications from the Combined Use of the Devices and Prognostic Risk Factors of Survival
por: Chatzis, Georgios, et al.
Publicado: (2021)

Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support
por: Chatzis, Georgios, et al.
Publicado: (2021)

Left Ventricle Architecture and Valvular Integrity Following Microaxial Mechanical Support: A Two-Year Follow-Up Study
por: Chatzis, Georgios, et al.
Publicado: (2021)

Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock
por: Markus, Birgit, et al.
Publicado: (2019)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

New Task Force Criteria Provide Evolution in Diagnosis of Arrhythmogenic Cardiomyopathy in Patients without Typical Progression of the Disease
por: Parahuleva, Mariana S., et al.
Publicado: (2017)

Analysis of Atrial Fibrillation Treatment Regimes in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
por: Waechter, Christian, et al.
Publicado: (2020)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

The Physiologic Basis and Clinical Outcomes of Combined Impella and Veno-Arterial Extracorporeal Membrane Oxygenation Support in Cardiogenic Shock
por: Lim, Hoong Sern
Publicado: (2020)

Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock
por: Hendrickson, Michael J., et al.
Publicado: (2022)

Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
por: Waechter, Christian, et al.
Publicado: (2022)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

Delayed perforation of an atrial pacemaker electrode: Lifelong risk for a rare but serious complication
por: Waechter, Christian, et al.
Publicado: (2023)

Impact of Rhythm vs. Rate Control in Atrial Fibrillation on the Long-Term Outcome of Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair
por: Waechter, Christian, et al.
Publicado: (2021)

Catheter ablation of concomitant atrial fibrillation improves survival of patients undergoing transcatheter edge-to-edge mitral valve repair
por: Ausbuettel, Felix, et al.
Publicado: (2023)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Left Ventricular Mechanical Support with the Impella during Extracorporeal Membrane Oxygenation
por: Moazzami, Kasra, et al.
Publicado: (2017)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Heparin-Induced Thrombocytopenia under Mechanical Circulatory Support by Large Impella for Acute Cardiogenic Shock
por: Sugimura, Yukiharu, et al.
Publicado: (2021)

The secretory phospholipase A(2) group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
por: Divchev, Dimitar, et al.
Publicado: (2008)

Combined Venoarterial ECMO and Impella-CP Circulatory Support for Cardiogenic Shock Due to Papillary Muscle Rupture
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case
por: Fox, Henrik, et al.
Publicado: (2017)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France
por: Le Guyader, Alexandre, et al.
Publicado: (2021)

Awake Implementation of Extracorporeal Life Support in Refractory Cardiogenic Shock
por: Riebandt, Julia, et al.
Publicado: (2021)

Extracorporeal life support in cardiogenic shock: indications and management in current practice
por: Meuwese, C. L., et al.
Publicado: (2018)

Extracorporeal Life Support for Cardiogenic Shock in Octogenarians: Single Center Experience
por: Scupakova, Nadezda, et al.
Publicado: (2023)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery
por: Sayed, Sameh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s866t0rpmqhp6gjb8tr5lvrmu3